News that fits you

Highlights

  • Novavax's vaccine gets approved for children
  • Novavax: vaccine was 80% effective against Covid-19
  • In India, Covovax is manufactured by Serum Institute of India.

Latest news

India, Russia are embarking on new journey of innovation, co-production and co-creation: PM Modi

India, Russia are embarking on new journey of innovation, co-production and co-creation: PM Modi

India is conducting independent and sovereign policy under leadership of PM Modi, achieving very good results: President Putin

India is conducting independent and sovereign policy under leadership of PM Modi, achieving very good results: President Putin

Indian businesses can replace void left by Western companies in Russia, says Roscongress CEO Stuglev

Indian businesses can replace void left by Western companies in Russia, says Roscongress CEO Stuglev

Regulator DGCA eases flight duty norms for pilots amid IndiGo crisis

Regulator DGCA eases flight duty norms for pilots amid IndiGo crisis

Dalai Lama launches 'Forest Resources in India' focused on climate, conservation and community

Dalai Lama launches 'Forest Resources in India' focused on climate, conservation and community

RBI raises FY26 GDP growth projection to 7.3 pc

RBI raises FY26 GDP growth projection to 7.3 pc

AAP to hold farmers’ Mahapanchayat in Gujarat's Amreli on December 7 amid crop loss crisis

AAP to hold farmers’ Mahapanchayat in Gujarat's Amreli on December 7 amid crop loss crisis

OnePlus marks 12 years in India with a new six-star lineup for the 15R reveal

OnePlus marks 12 years in India with a new six-star lineup for the 15R reveal

Covovax gets emergency use approval for children aged 12-17 in India

Covovax is the fourth Covid-19 vaccine to be authorised for adolescents aged 12 years and older in India after Biological E's Corbevax, Zydus Cadila's ZyCoV-D and Bharat Biotech's Covaxin.

Updated: Sep 02, 2022 10:53
|

Editorji News Desk

Covovax gets emergency use approval for children aged 12-17 in India

American biotechnology company Novavax has said that its Covid-19 vaccine has got emergency use authorisation for children in 12-17 years age group by India's drug regulator.

The company has claimed that its vaccine produced an immune response in the same age group in a mid- to late-stage study involving 460 Indian adolescents.

Last month Novavax had said its vaccine was 80% effective against Covid-19 in a late-stage trial testing the shot in 2,247 children aged 12 to 17 years.

The vaccine is manufactured in India by Serum Institute of India under the name of Covovax

Also watch: Covovax Explained: Adding another weapon to India's Covid arsenal

Covovax is the fourth Covid-19 vaccine to be authorised for adolescents aged 12 years and older in India after Biological E's Corbevax, Zydus Cadila's ZyCoV-D and Bharat Biotech's Covaxin.

ADVERTISEMENT

Up Next

Covovax gets emergency use approval for children aged 12-17 in India

Covovax gets emergency use approval for children aged 12-17 in India

Union minister says India's Covid vaccine programme more advanced than USA's

Union minister says India's Covid vaccine programme more advanced than USA's

Covid-19: minor drop in cases, deaths across India in 24 hours

Covid-19: minor drop in cases, deaths across India in 24 hours

Covid: India's daily new infections, active cases decline

Covid: India's daily new infections, active cases decline

Covid: India's active cases decline after nearly 70 days

Covid: India's active cases decline after nearly 70 days

Covid 19: India records 12,193 cases in last 24 hours

Covid 19: India records 12,193 cases in last 24 hours

ADVERTISEMENT

editorji-whatsApp

More videos

Covid surge: Centre asks states to keep strict vigil, take pre-emptive action

Covid surge: Centre asks states to keep strict vigil, take pre-emptive action

Tripura makes covid test mandatory for people arriving from states with high positivity rate

Tripura makes covid test mandatory for people arriving from states with high positivity rate

Covid: India sees slower rise in daily cases; 27 deaths in one day

Covid: India sees slower rise in daily cases; 27 deaths in one day

Delhi adds 1,396 Covid cases, positivity rate mounts to 31.9 per cent

Delhi adds 1,396 Covid cases, positivity rate mounts to 31.9 per cent

Covid entering endemic stage in India, cases likely to subside after 10-12 days

Covid entering endemic stage in India, cases likely to subside after 10-12 days

Covid: USA ends 'national emergency' after over 3 years

Covid: USA ends 'national emergency' after over 3 years

Nationwide Covid-19 drills begin to assess preparedness as cases surge

Nationwide Covid-19 drills begin to assess preparedness as cases surge

'The reason could be...': Indian Medical Association on surge in Covid-19 cases

'The reason could be...': Indian Medical Association on surge in Covid-19 cases

Covid cases likely to rise in the coming days, says Delhi health minister Saurabh Bhardwaj

Covid cases likely to rise in the coming days, says Delhi health minister Saurabh Bhardwaj

Battling long-Covid, this US woman smelled coffee after over 2 years | Watch her 1st reaction

Battling long-Covid, this US woman smelled coffee after over 2 years | Watch her 1st reaction

Categories

Editorji Technologies Pvt. Ltd. © 2022 All Rights Reserved.